title: Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
authors.affiliation: Department of Oncology-Pathology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Rodriguez-Wallberg
authors.affiliation: Department of Obstetrics and Gynecology, New York Medical College, Valhalla Innovation Institute for Fertility Preservation and IVF, New York.
authors.forename: V
authors.initials: V
authors.lastname: Turan
authors.affiliation: Helen Diller Cancer Center, University of California, San Francisco.
authors.forename: P
authors.initials: P
authors.lastname: Munster
authors.affiliation: Innovation Institute for Fertility Preservation and IVF, New York Laboratory of Molecular Reproduction and Fertility Preservation, Division of Reproductive Medicine, Department of Obstetrics and Gynecology, New York Medical College, Valhalla, USA koktay@fertilitypreservation.org.
authors.forename: K
authors.initials: K
authors.lastname: Oktay
mesh_terms: D000568:Amenorrhea / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D018572:Disease-Free Survival; D005260:Female; D005298:Fertility / Q000187:drug effects*; D059247:Fertility Preservation / Q000379:methods*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D065851:Ovarian Reserve / Q000187:drug effects* / Q000502:physiology; D010053:Ovary; D016649:Primary Ovarian Insufficiency / Q000188:drug therapy / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D007987:Gonadotropin-Releasing Hormone